EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Properties of Approved Antitumour Chinese Herbal Medicines: Integrating Evidence and Tradition

Linlin Qi iD, Shushu Qian, Ling Wang, Zhixu Liu, Jiaxin Jiang, Chunmei Liu, Yang Pan, Bo Wang, Xuan Han, Jing Chen iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s575608 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Linlin Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chines…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Medicine, Chinese Traditional, Antineoplastic Agents, Phytogenic, Neoplasms. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The properties and meridian affinities of Chinese herbal medicine are closely associated with their therapeutic efficacy. This review focuses on approved antitumour Chinese medicines listed in the Pharmacopoeia of the People's Republic of China (2020 Edition, Volume I), highlighting their key components. Statistical methods were used to analyse the properties, flavours and channel tropisms of antitumour traditional Chinese medicine (TCM), including both proprietary formulations and commercially available individual herbs. Distinctive patterns were identified by comparing herb profiles with contemporary experimental studies on antitumour TCM. Analysis revealed that bitter-cold herbs represented the highest proportion of antitumour TCM, with most showing tropism towards the liver channel. These findings provide a reference framework for antitumour drug development, indicating that bitter-cold herbs merit priority as candidate ingredients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalMedicine, Chinese TraditionalAntineoplastic Agents, PhytogenicNeoplasmsHumansAnimalsDrug Approval

Stichwörter der Autor:innen

antitumour traditional chinese medicinechannel tropismflavoursproperties

Substanzen

Drugs, Chinese HerbalAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • National Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Department of Rehabilitation Medicine, Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, H…
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Department of Biopharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.
  • School of Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.

ORCID-Profile: Linlin Qi, Jing Chen

Zitieren

APA

Qi, L., Qian, S., Wang, L., Liu, Z., Jiang, J., Liu, C., Pan, Y., Wang, B., Han, X., & Chen, J. (2026). Properties of Approved Antitumour Chinese Herbal Medicines: Integrating Evidence and Tradition. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s575608

Vancouver

Qi L, Qian S, Wang L, Liu Z, Jiang J, Liu C, et al. Properties of Approved Antitumour Chinese Herbal Medicines: Integrating Evidence and Tradition. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s575608

BibTeX
@article{Qi2026,
  author = {Qi, Linlin and Qian, Shushu and Wang, Ling and Liu, Zhixu and Jiang, Jiaxin and Liu, Chunmei and Pan, Yang and Wang, Bo and Han, Xuan and Chen, Jing},
  title = {Properties of Approved Antitumour Chinese Herbal Medicines: Integrating Evidence and Tradition},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s575608}
}
Kostenlos starten →